Skip to content

Serum or Plasma Free Light Chain Kappa (Mass Concentration)

Published: August 9, 2026Updated: August 16, 2026

This test measures the amount of free kappa light chains in your blood, which are small protein fragments produced by plasma cells. These fragments can be elevated in conditions affecting plasma cells, such as multiple myeloma or other blood disorders.

Quick summary

["Elevated levels may signal underlying blood or immune system conditions needing further evaluation."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
58882-2
Short code
GH sp23 SerPl-mCnc
Synonyms
GH sp23 SerPl-mCnc
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your healthcare provider may order this test if you have symptoms like unexplained fatigue, frequent infections, bone pain, or kidney problems. It’s also used to monitor certain blood cancers or autoimmune diseases. Sometimes, doctors check it when other blood tests show abnormal results.

What to Expect Before the Test

No special preparation is needed. You’ll likely have blood drawn from a vein in your arm. If you’re on blood thinners, let your provider know before the test.

What the Results Mean

Results are compared to a general range for healthy adults. High levels may indicate conditions like multiple myeloma, lymphoma, or other plasma cell disorders. Low levels alone usually don’t signal a problem unless combined with other symptoms or test results.

Common Conditions Linked to Results

Elevated free light chains are often linked to plasma cell disorders, such as multiple myeloma, where abnormal plasma cells produce too many light chains. They can also appear in other cancers (e.g., lymphoma) or inflammatory diseases. Kidney disease may also affect how these proteins are processed in your body.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

Free Light Chain Kappa

Frequently asked questions

What might cause abnormal results?
Abnormal results can occur in conditions like multiple myeloma, where plasma cells become overactive and produce too many light chains. They may also appear in other cancers (e.g., Waldenström macroglobulinemia), autoimmune diseases, or kidney problems. Rarely, genetic factors or certain medications could influence results.
How are results interpreted?
Your provider will review your results alongside other tests, symptoms, and medical history. High levels often prompt further testing (e.g., bone marrow biopsy) to diagnose or monitor conditions. Low levels alone usually aren’t concerning unless part of a broader evaluation.
Can lifestyle changes affect this test?
Lifestyle factors like diet, exercise, or stress may not directly impact free light chain levels, but they can influence overall health. If you’re on medications (e.g., blood thinners), always follow your provider’s instructions to avoid interfering with test accuracy.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy